These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20889977)

  • 1. Morphine modulation of thrombospondin levels in astrocytes and its implications for neurite outgrowth and synapse formation.
    Ikeda H; Miyatake M; Koshikawa N; Ochiai K; Yamada K; Kiss A; Donlin MJ; Panneton WM; Churchill JD; Green M; Siddiqui AM; Leinweber AL; Crews NR; Ezerskiy LA; Rendell VR; Belcheva MM; Coscia CJ
    J Biol Chem; 2010 Dec; 285(49):38415-27. PubMed ID: 20889977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic mu opioids differentially regulate thrombospondins 1 and 2 isoforms in astrocytes.
    Phamduong E; Rathore MK; Crews NR; D'Angelo AS; Leinweber AL; Kappera P; Krenning TM; Rendell VR; Belcheva MM; Coscia CJ
    ACS Chem Neurosci; 2014 Feb; 5(2):106-14. PubMed ID: 24304333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways.
    Miyatake M; Rubinstein TJ; McLennan GP; Belcheva MM; Coscia CJ
    J Neurochem; 2009 Jul; 110(2):662-74. PubMed ID: 19457093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mu opioid transactivation and down-regulation of the epidermal growth factor receptor in astrocytes: implications for mitogen-activated protein kinase signaling.
    Belcheva MM; Tan Y; Heaton VM; Clark AL; Coscia CJ
    Mol Pharmacol; 2003 Dec; 64(6):1391-401. PubMed ID: 14645669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid-induced mitogen-activated protein kinase signaling in rat enteric neurons following chronic morphine treatment.
    Duraffourd C; Kumala E; Anselmi L; Brecha NC; Sternini C
    PLoS One; 2014; 9(10):e110230. PubMed ID: 25302800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes.
    Belcheva MM; Clark AL; Haas PD; Serna JS; Hahn JW; Kiss A; Coscia CJ
    J Biol Chem; 2005 Jul; 280(30):27662-9. PubMed ID: 15944153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mu-Opioid receptor-induced Ca2+ mobilization and astroglial development: morphine inhibits DNA synthesis and stimulates cellular hypertrophy through a Ca(2+)-dependent mechanism.
    Hauser KF; Stiene-Martin A; Mattson MP; Elde RP; Ryan SE; Godleske CC
    Brain Res; 1996 May; 720(1-2):191-203. PubMed ID: 8782912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.
    Fujioka N; Nguyen J; Chen C; Li Y; Pasrija T; Niehans G; Johnson KN; Gupta V; Kratzke RA; Gupta K
    Anesth Analg; 2011 Dec; 113(6):1353-64. PubMed ID: 22003224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.
    Asensio VJ; Miralles A; García-Sevilla JA
    Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. μ Opioid Receptor-Triggered Notch-1 Activation Contributes to Morphine Tolerance: Role of Neuron-Glia Communication.
    Sanna MD; Borgonetti V; Galeotti N
    Mol Neurobiol; 2020 Jan; 57(1):331-345. PubMed ID: 31347026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regionally selective activation of ERK and JNK in morphine paradoxical hyperalgesia: a step toward improving opioid pain therapy.
    Sanna MD; Ghelardini C; Galeotti N
    Neuropharmacology; 2014 Nov; 86():67-77. PubMed ID: 24950452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in functional selectivity of morphine with the development of antinociceptive tolerance.
    Macey TA; Bobeck EN; Suchland KL; Morgan MM; Ingram SL
    Br J Pharmacol; 2015 Jan; 172(2):549-61. PubMed ID: 24666417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APP Binds to the EGFR Ligands HB-EGF and EGF, Acting Synergistically with EGF to Promote ERK Signaling and Neuritogenesis.
    da Rocha JF; Bastos L; Domingues SC; Bento AR; Konietzko U; da Cruz E Silva OAB; Vieira SI
    Mol Neurobiol; 2021 Feb; 58(2):668-688. PubMed ID: 33009641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain.
    Ramos-Miguel A; García-Sevilla JA
    Neuroscience; 2012 Jul; 215():17-30. PubMed ID: 22537847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombospondin-1 opens the paracellular pathway in pulmonary microvascular endothelia through EGFR/ErbB2 activation.
    Garg P; Yang S; Liu A; Pallero MA; Buchsbaum DJ; Mosher DF; Murphy-Ullrich JE; Goldblum SE
    Am J Physiol Lung Cell Mol Physiol; 2011 Jul; 301(1):L79-90. PubMed ID: 21531776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1/2 MAP kinase pathway.
    García-Fuster MJ; Miralles A; García-Sevilla JA
    Neuropsychopharmacology; 2007 Feb; 32(2):399-411. PubMed ID: 16482086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
    Dhandapani KM; Khan MM; Wade FM; Wakade C; Mahesh VB; Brann DW
    J Neurosci Res; 2007 Apr; 85(5):1033-45. PubMed ID: 17335076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta opioid activation of the mitogen-activated protein kinase cascade does not require transphosphorylation of receptor tyrosine kinases.
    Kramer HK; Onoprishvili I; Andria ML; Hanna K; Sheinkman K; Haddad LB; Simon EJ
    BMC Pharmacol; 2002; 2():5. PubMed ID: 11897012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of mu 3 opiate alkaloid receptors in macrophages, astrocytes, and HL-60 human promyelocytic leukemia cells.
    Makman MH; Dobrenis K; Surratt CK
    Adv Exp Med Biol; 1998; 437():137-48. PubMed ID: 9666265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mu-Opioid receptor-mediated ERK activation involves calmodulin-dependent epidermal growth factor receptor transactivation.
    Belcheva MM; Szùcs M; Wang D; Sadee W; Coscia CJ
    J Biol Chem; 2001 Sep; 276(36):33847-53. PubMed ID: 11457825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.